Home/Filings/4/0001596771-18-000020
4//SEC Filing

Reno Seth 4

Accession 0001596771-18-000020

CIK 0001638287other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:40 PM ET

Size

4.7 KB

Accession

0001596771-18-000020

Insider Transaction Report

Form 4
Period: 2018-02-08
Reno Seth
Chief Commercial Officer
Transactions
  • Purchase

    Common Stock

    2018-02-08$7.00/sh+14,286$100,00218,286 total
Footnotes (1)
  • [F1]The shares were purchased in a confidentially marketed public offering pursuant to an Underwriting Agreement. The offering closed on February 12, 2018.

Issuer

Gemphire Therapeutics Inc.

CIK 0001638287

Entity typeother

Related Parties

1
  • filerCIK 0001674004

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:40 PM ET
Size
4.7 KB